0001628280-24-032153.txt : 20240717
0001628280-24-032153.hdr.sgml : 20240717
20240717213147
ACCESSION NUMBER: 0001628280-24-032153
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240717
DATE AS OF CHANGE: 20240717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harris Taylor C.
CENTRAL INDEX KEY: 0001560168
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50644
FILM NUMBER: 241123570
MAIL ADDRESS:
STREET 1: 6035 STONERIDGE DRIVE
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUTERA INC
CENTRAL INDEX KEY: 0001162461
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 770492262
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 94005
MAIL ADDRESS:
STREET 1: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: ALTUS MEDICAL INC
DATE OF NAME CHANGE: 20011119
4
1
wk-form4_1721266300.xml
FORM 4
X0508
4
2024-07-15
0
0001162461
CUTERA INC
CUTR
0001560168
Harris Taylor C.
C/O CUTERA, INC.
3240 BAYSHORE BLVD.
BRISBANE
CA
94005
1
1
0
0
Chief Executive Officer
0
Stock Option (Right to Buy)
16.84
2024-07-15
4
D
0
25327
0
D
2030-05-19
COMMON STOCK
25327
0
D
Stock Option (Right to Buy)
1.54
2024-07-15
4
A
0
25327
0
A
2030-05-19
COMMON STOCK
25327
25327
D
Stock Option (Right to Buy)
11.02
2024-07-15
4
D
0
735295
0
D
2030-08-18
COMMON STOCK
735295
0
D
Stock Option (Right to Buy)
1.54
2024-07-15
4
A
0
735295
0
A
2030-08-18
COMMON STOCK
735295
735295
D
Stock Option (Right to Buy)
2.23
2024-07-15
4
D
0
200000
0
D
2031-05-13
COMMON STOCK
200000
0
D
Stock Option (Right to Buy)
1.54
2024-07-15
4
A
0
200000
0
A
2031-05-13
COMMON STOCK
200000
200000
D
One-third of the shares subject to the option vested on May 19, 2024 and one-third of the shares subject to the option vest each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
One-fourth of the shares subject to the option will be eligible to vest upon the date the 30 calendar-day trailing average closing price of the Issuer's common stock first meets each of the following levels within four years of the grant date: $20.00, $25.00, $30.00, and $35.00. Once a level is attained, one-fourth of the options subject to such tranche will vest on the later of (i) the date such level is attained or (ii) August 7, 2024. The remaining options in such tranche will vest over the next 12 quarters, subject to the Reporting Person continuing as a service provider through each such date.
The shares subject to the option shall vest 1/48 per month from April 25, 2024, subject to the Reporting Person continuing to be a service provider through each such date.
/s/ Stuart Drummond, by power of attorney
2024-07-17